Back to Search
Start Over
Cytokine storm in the pathophysiology of COVID-19: Possible functional disturbances of miRNAs
- Source :
- International Immunopharmacology
- Publication Year :
- 2021
-
Abstract
- SARS-CoV-2, as the causative agent of COVID-19, is an enveloped positives-sense single-stranded RNA virus that belongs to the Beta-CoVs sub-family. A sophisticated hyper-inflammatory reaction named cytokine storm is occurred in patients with severe/critical COVID-19, following an imbalance in immune-inflammatory processes and inhibition of antiviral responses by SARS-CoV-2, which leads to pulmonary failure, ARDS, and death. The miRNAs are small non-coding RNAs with an average length of 22 nucleotides which play various roles as one of the main modulators of genes expression and maintenance of immune system homeostasis. Recent evidence has shown that Homo sapiens (hsa)-miRNAs have the potential to work in three pivotal areas including targeting the virus genome, regulating the inflammatory signaling pathways, and reinforcing the production/signaling of IFNs-I. However, it seems that several SARS-CoV-2-induced interfering agents such as viral (v)-miRNAs, cytokine content, competing endogenous RNAs (ceRNAs), etc. preclude efficient function of hsa-miRNAs in severe/critical COVID-19. This subsequently leads to increased virus replication, intense inflammatory processes, and secondary complications development. In this review article, we provide an overview of hsa-miRNAs roles in viral genome targeting, inflammatory pathways modulation, and IFNs responses amplification in severe/critical COVID-19 accompanied by probable interventional factors and their function. Identification and monitoring of these interventional elements can help us in designing the miRNAs-based therapy for the reduction of complications/mortality rate in patients with severe/critical forms of the disease.
- Subjects :
- RhoB, Ras homolog gene family member B
M-CSF, Macrophage CSF
PPP2CA, Protein phosphatase 2 catalytic subunit alpha
RNA pol, RNA polymerase
medicine.medical_treatment
IRF, IFN regulatory factor
v-miRNA, Viral miRNA
DCs, Dendritic cells
MyD88, Myeloid differentiation factor 88
ISGs, IFN-stimulated genes
TLRs, Toll-like receptors
AT1R, Ang II receptor type 1
KCNQ1OT1, KCNQ1 overlapping transcript 1
CYLD, Cylindromatosis
IFNs-I, Type I IFNs
TNF-α, Tumor necrosis factor alpha
cPLA2, Cytoplasmic phospholipase A2
LPS, Lipopolysaccharide
Th cells, T helper cells
LPLs, Lysophospholipids
NLRP3, NOD-, LRR- and pyrin domain-containing protein 3
siRNAs, Small interfering RNAs
CNS, Central nervous system
pri-miRNAs, Primary miRNAs
MDA5, Melanoma differentiation-associated protein 5
ERK, Extracellular signal-regulated kinase
MERS-CoV, Middle East respiratory syndrome coronavirus
BBB, Blood-brain barrier
OxPLs, Oxidized phospholipids
MODS, Multiple organ dysfunction syndrome
mPGES-1, Microsomal prostaglandin E synthase-1
RNAi, RNA interference
ADAM17, A disintegrin and metalloproteinase 17
AGO, Argonaute
CRISPR, Cas13 family of clustered regularly interspaced short palindromic repeats
DAMPs, Damage-associated molecular patterns
circRNAs, Circular RNAs
CD, Cluster of differentiation
JAK, Janus kinase
TNFR, TNF receptor
Cytokine Release Syndrome
TRIM27, Tripartite motif-containing protein 27
gp130, Glycoprotein 130
MMP, Matrix metalloproteinase
2019-nCoV, 2019 novel coronavirus
CCL, C-C motif chemokine ligand
SOCS3, Suppressor of cytokine signaling 3
Immunology
COX, Cyclooxygenase
Sry, Sex-determining region Y
Article
S protein, Spike protein
microRNA
Humans
K, Lysine
CSF, Colony-stimulating factor
RGMB-AS1, RGMB antisense RNA 1
TIMP-I, Tissue inhibitors of matrix metalloproteinases-I
S100A9, S100 calcium-binding protein A9
Pharmacology
SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2
NOXs, Nicotinamide adenine dinucleotide phosphate (NADPH) oxidases
CHD, Coronary heart disease
STAT, Signal transducer and activator of transcription
Virus Internalization
medicine.disease
Viral replication
NF-κB, Nuclear factor kappa-light-chain-enhancer of activated B cells
miRNAs-based therapy
TBK1, TANK-binding kinase 1
ORF, Open reading frame
SOFA, Sequential organ failure assessment score
lncRNAs, Long non-coding RNAs
CatB/L, Cathepsin B/L
sIL-6R, Soluble IL-6R
ROS, Reactive oxygen species
EAE, Experimental autoimmune encephalomyelitis
RBCs, Red blood cells
MAPK, Mitogen-activated protein kinase
PBMCs, Peripheral blood mononuclear cells
N protein, Nucleocapsid protein
Ig, Immunoglobulin
Cytokine storm
Bioinformatics
Virus Replication
3'-UTR, 3'-untranslated region
H3, Histone 3
AGEs, Advanced glycation end products
Renin-Angiotensin System
XPO5, Exportin-5
G-CSF, Granulocyte CSF
CXCL, C-X-C motif chemokine ligand
DIC, Disseminated intravascular coagulation
Immunology and Allergy
IL, Interleukin
PG, Prostaglandin
RAS, Renin-Angiotensin system
Amp, Amplifier
MCs, Mast cells
COVID-19, Coronavirus disease 2019
HSP, Heat shock protein
AA, Arachidonic acid
ASOs, Antisense oligonucleotides
IFN, Interferon
mRNA, Messenger RNA
ICU, Intensive care unit
Cytokine
RAGE, Receptor for advanced glycation end products
mIL-6R, Membrane IL-6 receptor
FOXO3, Forkhead box O3
miRNAs
LTs, Leukotrienes
miRISC, MicroRNA-induced silencing complex
IκB-ζ, Inhibitor of nuclear factor kappa B zeta
Signal transduction
me3, Trimethylation
M protein, Membrane protein
APJ, Apelin receptor
AP-1, Activator protein 1
TMPRSS2, Transmembrane serine protease 2
PRR, Pattern recognition receptor
GM-CSF, Granulocyte-macrophage CSF
RIG-I, Retinoic acid-inducible gene I
E protein, Envelope protein
Biology
hsa, Homo sapiens
TXs, Thromboxanes
LOXs, Lipoxygenases
Virus
ER, Endoplasmic reticulum
ARDS, Acute respiratory distress syndrome
Gene regulators
medicine
me2, Dimethylation
Animals
PKCα, Protein kinase C alpha
pre-miRNAs, Precursor miRNAs
DMVs, Double membrane vesicles
ceRNAs, Competing endogenous RNAs
nsp, Non-structural protein
Competing endogenous RNA
SARS-CoV-2
ALI, Acute lung injury
PaO2/FiO2, Pressure of arterial oxygen to fractional inspired oxygen concentration
COVID-19
ACE, Angiotensin-converting enzyme
ANRIL, Antisense noncoding RNA in the INK4 locus
miRNAs, MicroRNAs
MEG3, Maternally expressed gene 3
Review article
MicroRNAs
DMD, Dense matted deposits
TAB, Transforming growth factor β-activated kinase-1 (TAK1)-binding protein
HMGB1, High mobility group box protein 1
Ang, Angiotensin
Subjects
Details
- ISSN :
- 18781705
- Volume :
- 101
- Database :
- OpenAIRE
- Journal :
- International immunopharmacology
- Accession number :
- edsair.doi.dedup.....fd4706f42d886bb679ed2a6b85453a9c